Survival after en bloc resection for locally invasive colorectal carcinoma

D. M. Mahvi*, M. Roskos, F. K. Storm

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Five percent of colorectal carcinomas invade contiguous structures at the time of primary surgical therapy. This study was designed to evaluate the survival of patients treated with en bloc resection of locally invasive colorectal cancer specifically regarding intraoperative decision-making. No difference was noted in either survival or recurrence on the basis of the site of primary disease or secondary structure resected. No patient with locally invasive colorectal carcinoma associated with nodal metastases (stage C3) remained free of disease and there were no 5-year survivors. In contrast, the 5-year survival of patients with local invasion and no lymph node metastases (stage B3) was 69%. In the absence of lymph node metastases, en bloc resection of primary colorectal carcinoma and locally invaded adjacent viscera offers survival equivalent to that of patients without local invasion, but functions only to prevent local recurrence in patients with lymph node metastases.

Original languageEnglish (US)
Pages (from-to)298-300
Number of pages3
JournalRegional Cancer Treatment
Volume4
Issue number5-6
StatePublished - Dec 1 1992

Fingerprint

Colorectal Neoplasms
Survival
Neoplasm Metastasis
Lymph Nodes
Recurrence
Viscera
Survivors
Decision Making
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Pharmacology

Cite this

Mahvi, D. M., Roskos, M., & Storm, F. K. (1992). Survival after en bloc resection for locally invasive colorectal carcinoma. Regional Cancer Treatment, 4(5-6), 298-300.
Mahvi, D. M. ; Roskos, M. ; Storm, F. K. / Survival after en bloc resection for locally invasive colorectal carcinoma. In: Regional Cancer Treatment. 1992 ; Vol. 4, No. 5-6. pp. 298-300.
@article{22dc5030fbf34539bd1208cf27a124d2,
title = "Survival after en bloc resection for locally invasive colorectal carcinoma",
abstract = "Five percent of colorectal carcinomas invade contiguous structures at the time of primary surgical therapy. This study was designed to evaluate the survival of patients treated with en bloc resection of locally invasive colorectal cancer specifically regarding intraoperative decision-making. No difference was noted in either survival or recurrence on the basis of the site of primary disease or secondary structure resected. No patient with locally invasive colorectal carcinoma associated with nodal metastases (stage C3) remained free of disease and there were no 5-year survivors. In contrast, the 5-year survival of patients with local invasion and no lymph node metastases (stage B3) was 69{\%}. In the absence of lymph node metastases, en bloc resection of primary colorectal carcinoma and locally invaded adjacent viscera offers survival equivalent to that of patients without local invasion, but functions only to prevent local recurrence in patients with lymph node metastases.",
author = "Mahvi, {D. M.} and M. Roskos and Storm, {F. K.}",
year = "1992",
month = "12",
day = "1",
language = "English (US)",
volume = "4",
pages = "298--300",
journal = "Regional Cancer Treatment",
issn = "0935-0411",
publisher = "Springer Verlag",
number = "5-6",

}

Mahvi, DM, Roskos, M & Storm, FK 1992, 'Survival after en bloc resection for locally invasive colorectal carcinoma', Regional Cancer Treatment, vol. 4, no. 5-6, pp. 298-300.

Survival after en bloc resection for locally invasive colorectal carcinoma. / Mahvi, D. M.; Roskos, M.; Storm, F. K.

In: Regional Cancer Treatment, Vol. 4, No. 5-6, 01.12.1992, p. 298-300.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Survival after en bloc resection for locally invasive colorectal carcinoma

AU - Mahvi, D. M.

AU - Roskos, M.

AU - Storm, F. K.

PY - 1992/12/1

Y1 - 1992/12/1

N2 - Five percent of colorectal carcinomas invade contiguous structures at the time of primary surgical therapy. This study was designed to evaluate the survival of patients treated with en bloc resection of locally invasive colorectal cancer specifically regarding intraoperative decision-making. No difference was noted in either survival or recurrence on the basis of the site of primary disease or secondary structure resected. No patient with locally invasive colorectal carcinoma associated with nodal metastases (stage C3) remained free of disease and there were no 5-year survivors. In contrast, the 5-year survival of patients with local invasion and no lymph node metastases (stage B3) was 69%. In the absence of lymph node metastases, en bloc resection of primary colorectal carcinoma and locally invaded adjacent viscera offers survival equivalent to that of patients without local invasion, but functions only to prevent local recurrence in patients with lymph node metastases.

AB - Five percent of colorectal carcinomas invade contiguous structures at the time of primary surgical therapy. This study was designed to evaluate the survival of patients treated with en bloc resection of locally invasive colorectal cancer specifically regarding intraoperative decision-making. No difference was noted in either survival or recurrence on the basis of the site of primary disease or secondary structure resected. No patient with locally invasive colorectal carcinoma associated with nodal metastases (stage C3) remained free of disease and there were no 5-year survivors. In contrast, the 5-year survival of patients with local invasion and no lymph node metastases (stage B3) was 69%. In the absence of lymph node metastases, en bloc resection of primary colorectal carcinoma and locally invaded adjacent viscera offers survival equivalent to that of patients without local invasion, but functions only to prevent local recurrence in patients with lymph node metastases.

UR - http://www.scopus.com/inward/record.url?scp=0027070652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027070652&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027070652

VL - 4

SP - 298

EP - 300

JO - Regional Cancer Treatment

JF - Regional Cancer Treatment

SN - 0935-0411

IS - 5-6

ER -